Month: May 2023

Dear Madam, Sir, Please find hereafter our press release regarding the extraordinary general meeting of 16 Juny 2023. We remain at your entire disposal for any further information. Yours sincerely.AttachmentsPress releaseCommuniqué de pressePersbericht

INSIDE INFORMATION BioSenic plans to further develop its program on an active injectable viscosupplement JTA, combining anti-pain and anti-inflammatory characteristics on a subtype of knee osteoarthritis. Mont-Saint-Guibert, Belgium, May 17th, 2023 7.00am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in serious autoimmune and inflammatory diseases and cell repair, today announces an update to its future plans for clinical development of BioSenic’s enhanced viscosupplement JTA. This includes BioSenic reacquiring intellectual property rights for the therapy. BioSenic announced in March 2023 that it had it has re-evaluated the results of its Phase III trial of its enhanced viscosupplement JTA-004 targeting knee osteoarthritis (OA). The original results from this trial were released on August 2021....

Six abstracts to be presented demonstrating efficacy and tolerability of investigational Bylvay in select cholestatic liver diseases New data emphasizes the consistent benefit of Bylvay as an investigational drug in Alagille syndrome and an approved medicine in PFIC, with evidence of rapid, sustained, and significant improvements in pruritus and sleep, and reductions in serum bile acids (sBAs) Further data shows evidence of disease modification with longer-term native liver survival in PFIC patientsPARIS, FRANCE, 17 May 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from its growing rare disease portfolio will be presented at the 55th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), taking place in Vienna, Austria 17-20 May 2023. The six data presentations,...

Press release May 17, 2023Gothenburg, Sweden Hexatronic Group authorizes share repurchase program The Board of Directors of Hexatronic Group AB (publ) (“Hexatronic”), with the authorization from the Annual General Meeting on May 9, 2023, has decided to repurchase a maximum of 1,200,000 of the company’s common stock on Nasdaq Stockholm during the period up until the Annual General Meeting in 2024. The purpose of the repurchase program is primarily to reduce dilution caused by the company’s outstanding share-based incentive programs. The purpose is also to use the repurchased shares as a means of payment in potential future corporate acquisitions. The repurchase of the company’s common stock will be carried out on Nasdaq Stockholm in accordance with the Nordic Main Market Rulebook for Issuers of Shares. The repurchases...

Press ReleaseVELIZY-VILLACOUBLAY, France — May 17, 2023 UK Atomic Energy Authority to Develop Fusion Energy Plant with Dassault Systèmes’ 3DEXPERIENCE PlatformUKAEA chooses the 3DEXPERIENCE platform for its spherical tokamak program to demonstrate the production of safe, virtually limitless and low-carbon energy Virtual twin experiences will support collaboration through the production of a concept design of a spherical tokamak by 2024 Deployment of the “Capital Facilities Information Excellence” industry solution experience based on the platform can improve productivity between 5% and 15%Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced that its 3DEXPERIENCE platform was selected for UKAEA’s Spherical Tokamak for Energy Production (STEP) program, which aims to deliver a prototype fusion energy plant, capable...

Baltic Horizon Fund has signed an agreement with ECRE IV (Lux) S.a.r.l. to sell 100% shares of BH Duetto UAB which owns Duetto I and II office buildings in Vilnius, Lithuania. The sales price of the assets is approximately EUR 37 million, which is close to the latest valuation. The exact sales price will be calculated on the closing date, however the price may be subject to post-closing adjustments. The fund first acquired the properties in 2017 and 2019 from the international developer and over the period earned an IRR of approximately 13.7% and equity multiple of 1.8x. The proceeds of the transaction will be used mainly to partially redeem the new bond and invest into the centrally located assets of the Fund. Closing of the transaction is expected to take place at the latest by 12 June 2023. “We continue to implement the investment...

Publication on May 17, 2023, before market openingRegulated and inside information – Business update 1Q23EVS Broadcast Equipment S.A.: Euronext Brussels (EVS.BR), Bloomberg (EVS BB), Reuters (EVSB.BR) EVS Q1 2023 business update Liège, Belgium, May 17th, 2023 Jump start into 2023 EVS takes a jump start in the new calendar year with the strong results of the first quarter. The achievements of the Q1 fully underpin EVS’ ambition to realize a profitable and sustainable growth in 2023. HighlightsA strong revenue for 1Q23 supporting our growth ambition for 2023. The secured revenue* calls for an upgrade of the revenue guidance for 2023 from an initial range of EUR 145-155 million to a range of EUR 150-160 million. Operational expenses are under control, demonstrating our objective to realize a profitable growth in 2023. Based on the 1Q23...